Neurocrine Bioscience buy JPMorgan Chase & Co.
Start price
13.09.23
/
50%
€107.25
Target price
13.09.24
€124.83
Performance (%)
18.32%
Price
10.05.24
€126.90
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ currently has a performance of 18.32%. This prediction currently runs until 13.09.24. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Neurocrine Bioscience | -2.907% | -2.907% |
iShares Core DAX® | 4.094% | 3.543% |
iShares Nasdaq 100 | 1.424% | 0.512% |
iShares Nikkei 225® | -1.572% | -4.633% |
iShares S&P 500 | 1.822% | 0.963% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at JPMorgan Chase & Co. from $133.00 to $134.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€128.85
20.03.24
20.03.24
€145.64
20.03.25
20.03.25
-1.51%
10.05.24
10.05.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€124.00
23.02.24
23.02.24
€136.69
23.02.25
23.02.25
2.34%
10.05.24
10.05.24